LSE Equity Snapshot
ONT Weekly Equity Report
Oxford Nanopore Technologies plc
What the company does
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry. It also provides PromethION products, such as PromethION 2, PromethION 24, and PromethION 48. The company has a collaboration with Cepheid to develop and commercialize automated infectious disease sequencing …
What the weekly tape is saying
ONT closed the latest completed week at 114.8 GBP. The 4-week return is -4.7% and the 12-week return is -4.2%. Trend Signal is inactive, Market Dynamics is 0.43. Setup signature: Risk-first tape with a 24/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 129.4 GBP
- Vs Trend Line
- -11.3%
- Fair Value
- 149.0 GBP
- Vs Fair Value
- -23.0%
- 52W High
- 224.8 GBP
- 52W Low
- 104.0 GBP
- Drawdown
- -48.9%
- Range Position
- 8.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 14
- 52W Active Breadth
- 26.9%
- Sector Scope
- GB Healthcare
- Sector Rank
- 74 of 78
- Sector Percentile
- 5.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
GB Healthcare
- Tracked Peers
- 78
- 4W Rank
- 44 of 78
- Avg 1W
- -2.0%
- Avg 4W
- -0.2%
- Trend Breadth
- 38.5%
- Positive MD
- 55.1%
GB Biotechnology
- Tracked Peers
- 29
- 4W Rank
- 15 of 29
- Avg 1W
- -3.7%
- Avg 4W
- -0.5%
- Trend Breadth
- 37.9%
- Positive RS
- 34.5%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.43
- 4W MD Change
- 149.4%
- Relative Strength
- -25.53
- 4W RS Change
- -25.0%
- Expectation
- Undecided
- Probability
- 48.31%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 4.3M
- 13W Average
- 7.0M
- 52W Average
- 9.9M
- Vs 13W
- 0.6x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.7%
- 52W Volatility
- 9.2%
- Upside Weeks
- 25
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 7.0% / -6.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- LSE
- Country
- GB
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- GBP
- Market Cap
- 1.4B
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 114.8 GBP | -11.9% | 129.4 GBP | 149.0 GBP | 0.43 | -25.53 | 4.3M | Off |
| 5 Jun 2026 | 130.3 GBP | -9.0% | 129.9 GBP | 149.7 GBP | 0.34 | -14.93 | 8.1M | Off |
| 29 May 2026 | 143.2 GBP | 10.7% | 130.3 GBP | 150.4 GBP | -0.11 | -7.00 | 5.7M | Off |
| 22 May 2026 | 129.4 GBP | 7.5% | 130.1 GBP | 151.3 GBP | -0.55 | -16.46 | 6.4M | Off |
| 15 May 2026 | 120.4 GBP | 6.5% | 130.5 GBP | 152.1 GBP | -0.86 | -20.42 | 8.1M | Off |
| 8 May 2026 | 113.1 GBP | -4.1% | 131.2 GBP | 152.9 GBP | -0.84 | -25.79 | 5.5M | Off |
| 1 May 2026 | 117.9 GBP | 2.6% | 132.3 GBP | 153.8 GBP | -0.79 | -24.00 | 4.1M | Off |
| 24 Apr 2026 | 114.9 GBP | -9.2% | 133.6 GBP | 154.5 GBP | -0.69 | -26.34 | 5.6M | Off |
| 17 Apr 2026 | 126.6 GBP | 16.7% | 134.8 GBP | 155.2 GBP | -0.61 | -21.34 | 12.3M | Off |
| 10 Apr 2026 | 108.5 GBP | -9.5% | 135.8 GBP | 155.8 GBP | -0.66 | -32.37 | 8.8M | Off |
| 3 Apr 2026 | 119.9 GBP | 5.5% | 137.7 GBP | 156.6 GBP | -0.58 | -24.50 | 7.2M | Off |
| 27 Mar 2026 | 113.6 GBP | -5.2% | 139.1 GBP | 157.3 GBP | -0.39 | -25.24 | 8.0M | Off |
| 20 Mar 2026 | 119.8 GBP | 2.3% | 141.3 GBP | 158.0 GBP | -0.22 | -20.85 | 7.1M | Off |
| 13 Mar 2026 | 117.1 GBP | -3.9% | 144.3 GBP | 158.5 GBP | -0.08 | -25.29 | 5.4M | Off |